Pharmaceutical Development Group, Inc.
Pharmaceutical Development Group (PDG) offers expert FDA regulatory consulting and strategic drug development services. They partner with life sciences companies to navigate complex regulatory pathways, ensuring product safety, efficacy, and commercial success.
Pharmaceutical Development Group (PDG), a subsidiary of Biotech Research Group Corporation, provides comprehensive FDA regulatory consulting and strategic drug development services. With extensive experience dating back to 1999, PDG assists drug and medical device companies in navigating the complexities of the FDA, from early-stage development through post-launch activities. Their expertise spans a wide range of services, including Pre-IND meetings, IND/SPA submissions, clinical trial design, NDA submissions (505(b)(1)/505(b)(2)), and generic drug applications (505(j) ANDAs). PDG also offers specialized consulting for medical devices, covering submissions like 510(k) and PMA, as well as facility inspection readiness and mock audits. PDG's team comprises seasoned professionals, including former FDA regulatory scientists and chemists, who leverage their deep understanding of regulatory requirements to maximize the safety, efficacy, and commercial value of their clients' products. They are dedicated to serving as long-term regulatory partners throughout the product lifecycle, ensuring compliance with cGMP, QSR, and other relevant international standards.
About
**Who they are**
Pharmaceutical Development Group, Inc. (PDG) is a life sciences consulting firm specializing in FDA regulatory consulting and strategic drug development services. They partner with companies to navigate complex regulatory pathways, ensuring product safety, efficacy, and commercial success.
**Expertise & scope**
* Expertise in FDA regulations and guidelines, providing insight into current regulatory interpretation.
* Support for FDA interactions through written documents, oral communication, and face-to-face meetings.
* Specialization in product development programs and strategies, data interpretation, gap analysis, and design/implementation of nonclinical and early phase clinical studies.
* Consultants experienced in supporting regulatory document preparations, including final study reports, investigator brochures, expert reports, and FDA response documents.
* Services include preclinical ADME (absorption, distribution, metabolism, excretion), pharmacology, and pharmacokinetic (PK) strategy and implementation.
* GLP (Good Laboratory Practice) report writing for toxicokinetics and pharmacokinetic studies.
* Extensive experience evaluating and advising on FDA, DMPK, and pharmacology/toxicology issues for various drug and biologic classes.
* Project managers and monitors provide oversight of preclinical studies, acting as the interface with contract research organizations (CROs).
**Reputation / proof points**
* Experience as former FDA supervisors, reviewers, and industry strategists.
Pharmaceutical Development Group, Inc. (PDG) is a life sciences consulting firm specializing in FDA regulatory consulting and strategic drug development services. They partner with companies to navigate complex regulatory pathways, ensuring product safety, efficacy, and commercial success.
**Expertise & scope**
* Expertise in FDA regulations and guidelines, providing insight into current regulatory interpretation.
* Support for FDA interactions through written documents, oral communication, and face-to-face meetings.
* Specialization in product development programs and strategies, data interpretation, gap analysis, and design/implementation of nonclinical and early phase clinical studies.
* Consultants experienced in supporting regulatory document preparations, including final study reports, investigator brochures, expert reports, and FDA response documents.
* Services include preclinical ADME (absorption, distribution, metabolism, excretion), pharmacology, and pharmacokinetic (PK) strategy and implementation.
* GLP (Good Laboratory Practice) report writing for toxicokinetics and pharmacokinetic studies.
* Extensive experience evaluating and advising on FDA, DMPK, and pharmacology/toxicology issues for various drug and biologic classes.
* Project managers and monitors provide oversight of preclinical studies, acting as the interface with contract research organizations (CROs).
**Reputation / proof points**
* Experience as former FDA supervisors, reviewers, and industry strategists.
Additional information
Pharmaceutical Development Group, Inc. emphasizes an experience-based approach to strategic, scientific, and regulatory services, aiming to focus and streamline client development efforts, thereby reducing both time and costs. They believe rigorous science and regulatory strategy are essential for clarifying the most efficient product development pathway. Their consultants customize services to individual client needs, leveraging a broad range of pharmaceutical development expertise. They also highlight a strategic alliance with Advyzom, a regulatory group providing support for global regulatory strategy, FDA liaison roles, clinical medical writing, and submissions.
Key Highlights
-
Offers expert FDA regulatory consulting and strategic drug development services.
Source
“Pharmaceutical Development Group (PDG) offers expert FDA regulatory consulting and strategic drug development services.”
-
Leverages experience as former FDA supervisors, reviewers, and industry strategists.
Source
“Aclairo’s experience as FDA supervisors, reviewers, and industry strategists has forged a unique comprehension of the product-specific complexities of pharmaceutical development.”
-
Specializes in product development programs, data interpretation, and gap analysis.
Source
“Aclairo specializes in product development programs and strategies, data interpretation, gap analysis, and design and implementation of nonclinical and early phase clinical studies.”
-
Provides GLP report writing for toxicokinetics and pharmacokinetic studies.
Source
“Aclairo now offers GLP report writing for toxicokinetics and pharmacokinetic studies.”
Certifications & Trust Signals
-
Founded on experience as FDA supervisors, reviewers, and industry strategists.
Source
“Aclairo’s experience as FDA supervisors, reviewers, and industry strategists has forged a unique comprehension of the product-specific complexities of pharmaceutical development.”
Buyer Snapshot
Best for
- Life sciences companies seeking FDA regulatory guidance.
- Organizations needing strategic drug development support.
- Clients requiring assistance with preclinical and clinical study planning and management.
How engagement typically works
- Collaborative partnership to navigate regulatory pathways.
- Customized service delivery based on client needs.
- Expert consultation and document preparation.
Typical deliverables
- Regulatory strategy and consulting.
- Scientific and regulatory writing (e.g., submission-ready documents).
- Preclinical study planning, management, and oversight.
- ADME/PK strategy and implementation.
- GLP TK/PK reports.
- FDA interaction support.
Good to know
- Best when clients require specialized expertise in pharmaceutical development and FDA regulations.
HQ:
Sterling, US
Languages:
English
Timezones:
EST
Claim status:
Listed
Services & Capabilities
Find FDA US Agent Services | Compare & Get Quotes
Jurisdictions:
US
Countries:
US
Inspection Support:
Yes
Product Type:
drugs
Additional us_agent_fda Details
Product Types
Pharmaceuticals, Biologics
Registration Support
No
Recall Support
No
Inspection Support
No
Emergency Contact24x7
No
US Entity State
VA
Onboarding Steps
No explicit mention of onboarding process, required documents, timeline, or setup steps.
⚡ Instant booking available
Appoint a Vetted FDA U.S. Agent in 2 Minutes
Compare Pharmaceutical Development Group, Inc. and other vetted providers — instant pricing, no RFQ needed.
